• 1
    Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002; 94: 471473.
  • 2
    Eley JW,Hill HA,Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: 947954.
  • 3
    Jatoi I,Anderson WF,Rao SR,Devesa SS. Breast cancer trends among black and white women in the United States. J Clin Oncol. 2005; 23: 78367841.
  • 4
    Blackman DJ,Masi CM. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol. 2006; 24: 21702178.
  • 5
    Wojcik BE,Spinks MK,Stein CR. Effects of screening mammography on the comparative survival rates of African American, white, and Hispanic beneficiaries of a comprehensive health care system. Breast J. 2003; 9: 175183.
  • 6
    Jatoi I,Becher H,Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare System. Cancer. 2003; 98: 894899.
  • 7
    Lilienfeld AM,Johnson EA. The age distribution in female breast and genital cancers. Cancer. 1955; 8: 875882.
  • 8
    Easton D. Breast cancer—not just whether but when? Nat Genet. 2000; 26: 390391.
  • 9
    Bernards R,Weinberg RA. Metastasis genes: a progression puzzle. Nature. 2002; 418: 823.
  • 10
    Hellman S,Harris JR. Natural history of breast cancer. In: HarrisJR,LippmanME,MorrowM,OsborneCK, editors. Diseases of the Breast.2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000: 407423.
  • 11
    Armitage P,Doll R. A 2-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br J Cancer. 1957; 11: 161169.
  • 12
    Armitage P,Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954; 8: 112.
  • 13
    Brinton LA,Lacey J,Devesa SS. Epidemiology of breast cancer. In: DoneganWL,SprattJS, editors. Cancer of the Breast.5th ed. Philadelphia: Saunders; 2002: 111132.
  • 14
    Pike MC,Spicer DV,Dahmoush L,Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993; 15: 1735.
  • 15
    Clemmesen J. Carcinoma of the breast. Br J Radiol. 1948; 21: 583590.
  • 16
    Anderson WF,Althuis MD,Brinton LA,Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat. 2004; 83: 7786.
  • 17
    Anderson WF,Matsuno RK. Breast cancer heterogeneity: a mixture of at least 2 main types. J Natl Cancer Inst. 2006; 98: 948951.
  • 18
    Anderson WF,Chatterjee N,Ershler WB,Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat. 2002; 76: 2736.
  • 19
    Anderson WF. Puberty and genetic susceptibility to breast cancer. N Engl J Med. 2003; 349: 10881089.
  • 20
    De Waard F,Baanders-van Halewijn EA,Huizinga J. The bimodal age distribution of patients with mammary carcinoma; evidence for the existence of 2 types of human breast cancer. Cancer. 1963; 17: 141151.
  • 21
    Anderson WF,Jatoi I,Devesa SS. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat. 2005; 90: 127137.
  • 22
    Cox B. Variation in the effectiveness of breast screening by year of follow-up. J Natl Cancer Inst Monogr. 1997; 22: 6972.
  • 23
    Retsky M,Demicheli R,Hrushesky W. Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy. Breast Cancer Res Treat. 2001; 65: 217224.
  • 24
    Demicheli R,Bonadonna G,Hrushesky WJM,Retsky MW,Valagussa P. Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening. J Clin Oncol. 2004; 22: 102107.
  • 25
    Baum M,Demicheli R,Hrushesky W,Retsky M. Does surgery unfavorably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer. 2005; 41: 508515.
  • 26
    Gukas ID. Does surgery induce angiogenesis in breast cancer? Supporting evidence from Africa. Int J Surg. 2005; 3: 289.
  • 27
    Margolis ML,Christie JD,Silvestri GA,Kaiser L,Santiago S,Hansen-Flaschen J. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003; 139: 558563.
  • 28
    Demicheli R,Bonadonna G,Hrushesky WJM,Retsky MW,Valagussa P. Menopausal status dependence of the timing of breast cancer recurrence following primary tumour surgical removal. Breast Cancer Res. 2004; 6: R689696.
  • 29
    Demicheli R,Terenziani M,Valagussa P,Moliterni A,Zambetti M,Bonadonna G. Local recurrences following mastectomy: support for the concept of tumour dormancy. J Natl Cancer Inst. 1994; 86: 4548.
  • 30
    Demicheli R,Abbattista A,Miceli R,Valagussa P,Bonadonna G. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumour dormancy. Breast Cancer Res Treat. 1996; 41: 177185.
  • 31
    Luzzi KJ,MacDonald IC,Schmidt EE, et al. Multistep nature of metastatic inefficiency. Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 1998; 153: 865873.
  • 32
    Naumov GN,MacDonald IC,Weinmeister PM, et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res. 2002; 62: 21622168.
  • 33
    Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995; 1: 2731.
  • 34
    Holmgren L,O'Reilly MS,Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995; 1: 149153.
  • 35
    Guba M,Cernaianu G,Koehl G, et al. A primary tumour promotes dormancy of solitary tumour cells before inhibiting angiogenesis. Cancer Res. 2001; 61: 55755579.
  • 36
    O'Reilly MS,Holmgren L,Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994; 79: 315328.
  • 37
    Simpson-Herren L,Sanford AH,Holmquist JP. Effects of surgery on the cell kinetics of residual tumour. Cancer Treat Rep. 1976; 60: 17491760.
  • 38
    Gunduz N,Fisher B,Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumour. Cancer Res. 1982; 39: 38613865.
  • 39
    Demicheli R,Retsky MW,Swartzendruber DE,Bonadonna G. Proposal for a new model of breast cancer metastatic development. Ann Oncol. 1997; 8: 10751080.
  • 40
    Retsky MW,Demicheli R,Swartzendruber DE, et al. Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat. 1997; 45: 193202.
  • 41
    Demicheli R,Miceli R,Moliterni A, et al. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumour dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol. 2005; 16: 14491457.
  • 42
    Demicheli R,Valagussa P,Bonadonna G. Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy. Breast Cancer Res Treat. 2002; 75: 127134.
  • 43
    Retsky M,Demicheli R,Hrushesky WJM. Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox. Int J Surg. 2005; 3: 179187.
  • 44
    Perou CM,Sorlie T,Eisen MB, et al. Molecular portraits of human breast tumors. Nature. 2000; 406: 747752.
  • 45
    Bissell MJ,Weaver VM,Lelievre SA,Wang F,Petersen OW,Schmeichel KL. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res. 1999; 59: 17571763.
  • 46
    Maffini MV,Soto AM,Calabro JM,Ucci AA,Sonnenschein C. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci. 2004; 117: 14951502.
  • 47
    McDaniel SM,Rumer KK,Biroc SL, et al. Remodelling of the mammary microenvironment after lactation promotes breast tumour cell metastasis. Am J Pathol. 2006; 168: 608620.
  • 48
    Cooper AP. In: LeeA, editor. Practice and Principles of Surgery. London: E. Cox; 1836.
  • 49
    Beatson GT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet. 1896; II: 104107.
  • 50
    Hrushesky WJM. Commentary: rhythmic menstrual cycle modulation of breast cancer biology. J Surg Oncol. 2000; 74: 238241.
  • 51
    Anderson T. Mitotic activity in breast. J Obstet Gynecol. 1984; 4: S114S118.
  • 52
    Wood PA,Bove K,You S,Chambers A,Hrushesky WJM. Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther. 2005; 4: 10651075.
  • 53
    Wood PA,Hrushesky WJM. Sex cycle modulates cancer growth. Breast Cancer Res Treat. 2005; 91: 95102.
  • 54
    Manson JM,Sammel MD,Freeman EW,Grisso JA. Racial differences in sex hormone levels in women approaching the transition to menopause. Fertil Steril. 2001; 75: 297304.
  • 55
    Pinheiro SP,Holmes MD,Pollak MN,Barbieri RL,Hnkinson SE. Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev. 2005; 14: 21472153.
  • 56
    Herman-Giddens ME,Slora EJ,Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics. 1997; 99: 505512.
  • 57
    Kato I,Toniolo P,Koenig KL, et al. Epidemiologic correlates with menstrual cycle length in middle aged women. Eur J Epidemiol. 1999; 15: 809814.
  • 58
    Hrushesky WJ,Bluming AZ,Gruber SA. Menstrual influence on surgical cure of breast cancer [letter]. Lancet. 1990; 335: 984.
  • 59
    Hrushesky WJM. Breast cancer, timing of surgery, and the menstrual cycle: call for prospective trial. J Women's Health. 1996; 5: 555565.
  • 60
    Love RR,Duc NB,Dinh NV, et al. Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer. J Natl Cancer Inst. 2002; 94: 662669.
  • 61
    Sorlie T,Wang Y,Xiao C, et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across 3 different platforms. BMC Genomics. 2006; 7: 127.
  • 62
    Gasparini G,Dal Fior S,Pozza F,Bevilacqua P. Correlation of growth fraction by Ki-67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma. Breast Cancer Res Treat. 1989; 14: 329336.
  • 63
    Demicheli R,Bonadonna G,Greco M, et al. Comment to Anderson WF, Jatoi I, Devesa SS: Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat. 2005; 90: 127137.Breast Cancer Res Treat.2006;97:341–343 (Comment).
  • 64
    Sorlie T,Perou CM,Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98: 1086910874.
  • 65
    Sotiriou C,Neo S-Y,McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003; 100: 1039310398.